Effects of HMGA2 on migration and proliferation of leptomeningeal metastatic melanoma

doi:10.19401/j.cnki.1007-3639.2024.04.006

Abstract

Abstract:

Background and purpose: Leptomeningeal metastasis is a form of central nervous system metastasis of melanoma. High mobility group A2 (HMGA2) has been proven to play an important role in the occurrence and development of various tumors, but its biological functions in leptomeningeal metastatic melanoma cells remain unclear. On the basis of building mouse models of central nervous system metastasis of melanoma, this study investigated the differences in cell migration and cell proliferation among leptomeningeal metastatic melanoma cells, primary site melanoma cells and brain parenchymal metastatic melanoma cells, and further clarified the effects of differentially expressed gene HMGA2 on cell migration and proliferation of leptomeningeal metastatic melanoma cells. Methods: B16 mouse melanoma cells (B16-parental cells, B16-Par) stably expressing tdTomato and luciferase were generated by lentiviral infection. Subsequently, B16 specific brain parenchymal metastatic cells (B16-brain metastatic cells, B16-BrM) and B16 specific leptomeningeal metastatic cells (B16-leptomeningeal metastatic cells, B16-LM) were collected after adaptive screening of metastatic sites in vivo. The differences in migration and proliferation among B16-Par, B16-BrM and B16-LM were assessed by wound healing assay and cell counting kit-8 (CCK-8). RNA sequencing (RNA-seq) was used to analyze differential gene expression in B16-Par, B16-BrM and B16-LM, and HMGA2 gene specifically upregulated in B16-LM was screened out. The results were verified by real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR) and Western blot. Gene ontology (GO) analysis was performed for genes which were upregulated in B16-LM specifically. siRNA was used to interfere with the expression of HMGA2 gene in B16-LM, and the knock-down effect was verified by RTFQ-PCR and Western blot. The effects of knocking down HMGA2 on cell migration and proliferation were detected by wound healing assay and CCK-8 assay. Using GSE174401 data in Gene Expression Omnibus (GEO), the specificity of HMGA2 gene expression in leptomeningeal metastatic melanoma cells from patients was verified. Results: Compared with Par cells, tumor cells screened by the brain environment were more likely to colonize the central nervous system. B16-LM had stronger migration and proliferation abilities, and upregulated the expression of HMGA2 gene. GO analysis revealed that HMGA2 was associated with many biological processes such as angiogenesis and cell proliferation. When the expression of HMGA2 gene was knocked down, the migration and proliferation of B16-LM could be inhibited. HMGA2 was upregulated in leptomeningeal metastatic melanoma cells from patients. Conclusion: Leptomeningeal metastatic melanoma cells had relatively unique cellular characteristics, which promoted cell migration and proliferation by upregulating HMGA2 gene expression.

Key words: Melanoma, Central nervous system metastasis, Leptomeningeal metastasis, Brain metastasis, HMGA2

CLC Number:

LI Xiaohui, ZHAO Jiaxu, PENG Haibao, ZHANG Ye, ZENG Rui, CHI Yudan. Effects of HMGA2 on migration and proliferation of leptomeningeal metastatic melanoma[J]. China Oncology, 2024, 34(4): 389-399.

Figures/Tables 9

Fig. 1

Fig. 2

Fig. 3

Fig. 4

Tab. 1

Fig. 5

Fig. 6

Fig. 7

Fig. 8

References 25

[1]	SCHADENDORF D, VAN AKKOOI A C J, BERKING C, et al. Melanoma[J]. Lancet, 2018, 392(10151): 971-984. doi: S0140-6736(18)31559-9 pmid: 30238891
[2]	KENCHAPPA R S, TRAN N, RAO N G, et al. Novel treatments for melanoma brain metastases[J]. Cancer Control, 2013, 20(4): 298-306. pmid: 24077406
[3]	SMALLEY I, CHEN Z H, PHADKE M, et al. Single-cell characterization of the immune microenvironment of melanoma brain and leptomeningeal metastases[J]. Clin Cancer Res, 2021, 27(14): 4109-4125.
[4]	FIFE K M, COLMAN M H, STEVENS G N, et al. Determinants of outcome in melanoma patients with cerebral metastases[J]. J Clin Oncol, 2004, 22(7): 1293-1300. doi: 10.1200/JCO.2004.08.140 pmid: 15051777
[5]	SAMPSON J H, CARTER J H, FRIEDMAN A H, et al. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma[J]. J Neurosurg, 1998, 88(1): 11-20. doi: 10.3171/jns.1998.88.1.0011 pmid: 9420067
[6]	SONG Q Q, RUIZ J, XING F, et al. Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment[J]. Commun Biol, 2023, 6(1): 760. doi: 10.1038/s42003-023-05124-2 pmid: 37479733
[7]	CHI Y D, REMSIK J, KISELIOVAS V, et al. Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis[J]. Science, 2020, 369(6501): 276-282. doi: 10.1126/science.aaz2193 pmid: 32675368
[8]	BOIRE A, ZOU Y L, SHIEH J, et al. Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis[J]. Cell, 2017, 168(6): 1101-1113.e13. doi: S0092-8674(17)30240-4 pmid: 28283064
[9]	NOLAN C, DEANGELIS L M. Overview of metastatic disease of the central nervous system[J]. Handb Clin Neurol, 2018, 149: 3-23. doi: B978-0-12-811161-1.00001-3 pmid: 29307359
[10]	MANSOORI B, MOHAMMADI A, DITZEL H J, et al. HMGA2 as a critical regulator in cancer development[J]. Genes (Basel), 2021, 12(2): 269.
[11]	HASHEMI M, RASHIDI M, HUSHMANDI K, et al. HMGA2 regulation by miRNAs in cancer: affecting cancer hallmarks and therapy response[J]. Pharmacol Res, 2023, 190: 106732.
[12]	XU J X, FANG X J, LONG L Y, et al. HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway[J]. Cancer Biol Ther, 2021, 22(1): 5-11. doi: 10.1080/15384047.2020.1832429 pmid: 33307962
[13]	ZHANG S, ZHANG H, YU L. HMGA2 promotes glioma invasion and poor prognosis via a long-range chromatin interaction[J]. Cancer Med, 2018, 7(7): 3226-3239.
[14]	KAUR H, ALI S Z, HUEY L, et al. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma[J]. Cancer Lett, 2016, 377(1): 55-64. doi: 10.1016/j.canlet.2016.04.020 pmid: 27102002
[15]	VAN DER MAATEN L, HINTON G. Visualizing data using t-SNE[J]. J Mach Learn Res, 2008, 9: 2579-605.
[16]	KOZOVSKA Z, GABRISOVA V, KUCEROVA L. Malignant melanoma: diagnosis, treatment and cancer stem cells[J]. Neoplasma, 2016, 63(4): 510-517. doi: 10.4149/neo_2016_403 pmid: 27268913
[17]	YDE S S, SJOEGREN P, HEJE M, et al. Mucosal melanoma: a literature review[J]. Curr Oncol Rep, 2018, 20(3): 1-10.
[18]	韩如雪, 梁翔, 马旭辉, 等. 口腔黏膜恶性黑色素瘤肺转移特征及预后分析[J]. 中国癌症杂志, 2022, 32(12): 1184-1189. doi: 10.19401/j.cnki.1007-3639.2022.12.006
	HAN R X, LIANG X, MA X H, et al. Characteristics and prognostic analysis of oral mucosal melanoma with lung metastasis[J]. China Oncol, 2022, 32(12): 1184-1189.
[19]	STEININGER J, GELLRICH F F, ENGELLANDT K, et al. Leptomeningeal metastases in melanoma patients: an update on and future perspectives for diagnosis and treatment[J]. Int J Mol Sci, 2023, 24(14): 11443.
[20]	PAPE E, DESMEDT E, ZAIRI F, et al. Leptomeningeal metastasis in melanoma: a prospective clinical study of nine patients[J]. In Vivo, 2012, 26(6): 1079-1086. pmid: 23160697
[21]	THAKKAR J P, KUMTHEKAR P, DIXIT K S, et al. Leptomeningeal metastasis from solid tumors[J]. J Neurol Sci, 2020, 411: 116706.
[22]	RAIZER J J, HWU W J, PANAGEAS K S, et al. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features[J]. Neuro Oncol, 2008, 10(2): 199-207.
[23]	XIONG L, TANG Y, TANG J, et al. Downregulation of lncRNA HOTTIP suppresses the proliferation, migration, and invasion of oral tongue squamous cell carcinoma by regulation of HMGA2-mediated Wnt/β-catenin pathway[J]. Cancer Biother Radiopharm, 2020, 35(9): 720-730.
[24]	LIU C M, ZHENG S F, WANG Z Y, et al. KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer[J]. Cancer Commun (Lond), 2022, 42(9): 828-847.
[25]	WANG X, WANG J, ZHAO J H, et al. HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment[J]. Theranostics, 2022, 12(2): 963-975. doi: 10.7150/thno.65411 pmid: 34976223